Enlivex Therapeutics (NASDAQ:ENLV – Get Rating) and Scopus BioPharma (NASDAQ:SCPS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Profitability This table compares Enlivex Therapeutics and Scopus BioPharma’s […]
Now in its fourth year, “Hadassah On Call: New Frontiers in Medicine” has explored groundbreaking medical solutions like stem cell harvesting and corneal transplantation; new treatments for cancer, cardiac disease and other often life-threatening illnesses; myriad aspects of COVID-19; chronic conditions like joint pain, sleeplessness and headaches; physical and emotional trauma, including sexual abuse and PTSD; and issues connected to sexuality, infertility and menopause, to name just some of the topics addressed over the course of almost 60 episodes.
The social media gods now think they hold more authority than actual public health authorities like Florida Attorney General Dr. Joseph A. Ladapo, who was suspended from Twitter for advising [.]
Risk for Myocarditis Low After BNT162b2 Booster in Israel kxly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kxly.com Daily Mail and Mail on Sunday newspapers.
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNT